Biostatistics

Pharmacokinetics

Pharmacodynamics
 
   
 

ClinTrialStat Statistical Analysis Services combines sound analytical judgment, agile modeling methods, and expert statistical programming to support all phases of clinical development.

ClinTrialStat Analysis Teams specialize in creating strategic advantages for you and your company through careful planning, attention to detail, and expert modeling applications. Armed with reliable SAS programming, qualification procedures, and powerful technology made available through SapMaker Content 2.0 and SapMaker Table 3.4. Due to this advantage we are poised and well-equipped to bring attractively priced, full-service analysis support to your clinical development and clinical pharmacology projects.

Statistical Analysis Services

    Clinical endpoint and experimental design development.
    Sample size and power for parallel, crossover and replicated designs.
    Preparation for Statistical Analysis Plans
    Subject randomization using central and stratified adaptive methods
    Statistical analysis of clinical endpoints, statistical programming & validation
    Comprehensive generation of ICH summary tables, figures, and listings
    Meta analysis and mixed-effects modeling
    Submission support, including preparation of safety & efficacy summaries (ISS/ISE)
    Interim analysis and reporting
    Exploratory analysis, ad hoc and custom data summaries
    Regulatory guidance and liaison support with regulatory agencies
     

Pharmacokinetics and Pharmcodynamic Modeling

    Pharmacokinetics analysis planning and optimal sampling strategies
    Tabulation, display, analysis and interpretation of concentration-time data
    Non-compartmental analysis (WinNonlin) -- Pharmacokinetics and Pharmodynamic analysis
    Compartmental PK/PD Modeling and Simulation (WinNonlin or NONMEM)
    Parametric/Nonparametric Population PK/PD Analysis and Simulation (NONMEN)
    Individual and population bioequivalence analysis
    Modeling and simulation of diverse dosing and sampling strategies
    Steady-state determination, evaluation and analysis using efficient iterative measures
    Use of biomarkers for individual and population PK/PD analysis and data interpretation